Total assets increased 56.5%
Total assets changed +56.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$527.5M→$825.7M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →AUPH financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 18.9%
Operating income changed +18.9% from the comparable as-filed period.
$29.7M→$35.4M2 prior comparisons
Operating margin moved 176 bp higher
Operating margin changed +176 basis points from the comparable as-filed period.
40.49%→42.25%2 prior comparisons
Research & development increased 97.0%
Research & development changed +97.0% from the comparable as-filed period.
$8.4M→$16.6M2 prior comparisons
Cash & equivalents decreased 37.2%
Cash & equivalents changed -37.2% from the comparable as-filed period.
$72.9M→$45.8M3 prior comparisons
Inventory / revenue moved 873 bp lower
Inventory / revenue changed -873 basis points from the comparable as-filed period.
60.97%→52.24%2 prior comparisons
Current liabilities increased 27.6%
Current liabilities changed +27.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$78.3M→$99.9M4 prior comparisons
Operating income increased 130.7%
Operating income changed +130.7% from the comparable as-filed period.
$20.1M→$46.3M2 prior comparisons
Operating margin moved 2700 bp higher
Operating margin changed +2700 basis points from the comparable as-filed period.
28.69%→55.68%2 prior comparisons
Cash & equivalents increased 239.7%
Cash & equivalents changed +239.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$52.9M→$179.7M3 prior comparisons
Operating cash flow increased 18.8%
Operating cash flow changed +18.8% from the comparable as-filed period.
$44.2M→$52.6M3 prior comparisons
Gross margin moved 229 bp higher
Gross margin changed +229 basis points from the comparable as-filed period.
89.84%→92.12%2 prior comparisons
Research & development increased 75.6%
Research & development changed +75.6% from the comparable as-filed period.
$7.4M→$13.1M2 prior comparisons
Revenue increased 18.9%
Revenue changed +18.9% from the comparable as-filed period.
$70.0M→$83.2M2 prior comparisons
Inventory / revenue moved 1217 bp lower
Inventory / revenue changed -1217 basis points from the comparable as-filed period.
66.43%→54.25%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.